Long-term outcomes of rituximab (RTX) therapy in recurrent Granulomatosis with Polyangiitis (GPA)

D. Gawryluk (Warsaw, Poland), J. Fijolek (Warsaw, Poland), E. Wiatr (Warsaw, Poland)

Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Session: Granulomatous disorders: heterogeneous diseases with variable management
Session type: Thematic Poster
Number: 3009

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Gawryluk (Warsaw, Poland), J. Fijolek (Warsaw, Poland), E. Wiatr (Warsaw, Poland). Long-term outcomes of rituximab (RTX) therapy in recurrent Granulomatosis with Polyangiitis (GPA). 3009

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: